These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 15126111)

  • 1. Chronic morphine-induced loss of the facilitative interaction between vasoactive intestinal polypeptide and delta-opioid: involvement of protein kinase C and phospholipase Cbetas.
    Liu NJ; Chakrabarti S; Gintzler AR
    Brain Res; 2004 Jun; 1010(1-2):1-9. PubMed ID: 15126111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Facilitative interactions between vasoactive intestinal polypeptide and receptor type-selective opioids: implications for sensory afferent regulation of spinal opioid action.
    Liu NJ; Gintzler AR
    Brain Res; 2003 Jan; 959(1):103-10. PubMed ID: 12480163
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Supraspinal antinociceptive response to [D-Pen(2,5)]-enkephalin (DPDPE) is pharmacologically distinct from that to other delta-agonists in the rat.
    Fraser GL; Pradhan AA; Clarke PB; Wahlestedt C
    J Pharmacol Exp Ther; 2000 Dec; 295(3):1135-41. PubMed ID: 11082450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of phospholipase C-beta3 phosphorylation to the rapid attenuation of opioid-activated phosphoinositide response.
    Strassheim D; Law PY; Loh HH
    Mol Pharmacol; 1998 Jun; 53(6):1047-53. PubMed ID: 9614207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase Cbeta1 modulates pain sensitivity, opioid antinociception and opioid tolerance formation.
    Liu NJ; vonGizycki H; Gintzler AR
    Brain Res; 2006 Jan; 1069(1):47-53. PubMed ID: 16405873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice.
    Szentirmay AK; Király KP; Lenkey N; Lackó E; Al-Khrasani M; Friedmann T; Timár J; Gyarmati S; Tóth G; Fürst S; Riba P
    Brain Res Bull; 2013 Jan; 90():66-71. PubMed ID: 22995282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional reduction in mu-opioidergic system in the spinal cord under a neuropathic pain-like state following chronic ethanol consumption in the rat.
    Narita M; Miyoshi K; Narita M; Suzuki T
    Neuroscience; 2007 Feb; 144(3):777-82. PubMed ID: 17156932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of the antinociceptive effect of acute morphine in female and male Sprague-Dawley rats using the long-lasting mu-antagonist methocinnamox.
    Peckham EM; Barkley LM; Divin MF; Cicero TJ; Traynor JR
    Brain Res; 2005 Oct; 1058(1-2):137-47. PubMed ID: 16139823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of the protein kinase Cgamma isoform in development of tolerance to nitrous oxide-induced antinociception in mice.
    Matsushita Y; Ishikawa M; Abe K; Utsunomiya I; Chikuma T; Hojo H; Hoshi K; Quock RM; Taguchi K
    Neuroscience; 2007 Aug; 148(2):541-7. PubMed ID: 17681696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reciprocal modulation of phospholipase Cbeta isoforms: adaptation to chronic morphine.
    Chakrabarti S; Liu NJ; Gintzler AR
    Proc Natl Acad Sci U S A; 2003 Nov; 100(23):13686-91. PubMed ID: 14597703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased level of neuronal phosphoinositide 3-kinase gamma by the activation of mu-opioid receptor in the mouse periaqueductal gray matter: further evidence for the implication in morphine-induced antinociception.
    Narita M; Imai S; Narita M; Kasukawa A; Yajima Y; Suzuki T
    Neuroscience; 2004; 124(3):515-21. PubMed ID: 14980723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Direct involvement of the supraspinal phosphoinositide 3-kinase/phospholipase C gamma 1 pathway in the mu-opioid receptor agonist-induced supraspinal antinociception in the mouse].
    Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Jun; 23(3):121-8. PubMed ID: 12884752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mu-Opioid receptor internalization-dependent and -independent mechanisms of the development of tolerance to mu-opioid receptor agonists: Comparison between etorphine and morphine.
    Narita M; Suzuki M; Narita M; Niikura K; Nakamura A; Miyatake M; Yajima Y; Suzuki T
    Neuroscience; 2006; 138(2):609-19. PubMed ID: 16417975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of protein kinase C and cAMP-dependent protein kinase by delta-opioid.
    Lou LG; Pei G
    Biochem Biophys Res Commun; 1997 Jul; 236(3):626-9. PubMed ID: 9245701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antiexudative effects of opioids and expression of kappa- and delta-opioid receptors during intestinal inflammation in mice: involvement of nitric oxide.
    Jiménez N; Puig MM; Pol O
    J Pharmacol Exp Ther; 2006 Jan; 316(1):261-70. PubMed ID: 16183704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underlying mechanisms of pronociceptive consequences of prolonged morphine exposure.
    Ossipov MH; Lai J; King T; Vanderah TW; Porreca F
    Biopolymers; 2005; 80(2-3):319-24. PubMed ID: 15795927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antisense oligonucleotide knockdown of mGlu₅ receptor attenuates the antinociceptive tolerance and up-regulated expression of spinal protein kinase C associated with chronic morphine treatment.
    Xu T; Chen M; Zhou Q; Xue Y; Wang L; Bil De Arce VJ; Zhang X; Jiang W
    Eur J Pharmacol; 2012 May; 683(1-3):78-85. PubMed ID: 22429573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
    Asensio VJ; Miralles A; García-Sevilla JA
    Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. delta Opioid receptor subtypes activate inositol-signaling pathways in the production of antinociception.
    Sánchez-Blázquez P; Garzón J
    J Pharmacol Exp Ther; 1998 May; 285(2):820-7. PubMed ID: 9580632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultra-low-dose naloxone suppresses opioid tolerance, dependence and associated changes in mu opioid receptor-G protein coupling and Gbetagamma signaling.
    Wang HY; Friedman E; Olmstead MC; Burns LH
    Neuroscience; 2005; 135(1):247-61. PubMed ID: 16084657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.